DarioHealth (NASDAQ:DRIO) reported quarterly losses of $(0.25) per share which beat the analyst consensus estimate of $(0.27) by 7.41 percent. The company reported quarterly sales of $7.423 million which beat the analyst consensus estimate of $7.397 million by 0.36 percent. This is a 111.00 percent increase over sales of $3.518 million the same period last year.